APA (7th ed.) Citation

FR, D. P., R, F., S, V., G, P., CM, F., ML, C., . . . F, D. G. (2026). Case Report: The role of BRAF mutation in adjuvant and neoadjuvant treatment of melanoma patients: what is the optimal approach? Frontiers in oncology, 16, 1775350. https://doi.org/10.3389/fonc.2026.1775350

Chicago Style (17th ed.) Citation

FR, Di Pietro, et al. "Case Report: The Role of BRAF Mutation in Adjuvant and Neoadjuvant Treatment of Melanoma Patients: What Is the Optimal Approach?" Frontiers in Oncology 16 (2026): 1775350. https://doi.org/10.3389/fonc.2026.1775350.

MLA (9th ed.) Citation

FR, Di Pietro, et al. "Case Report: The Role of BRAF Mutation in Adjuvant and Neoadjuvant Treatment of Melanoma Patients: What Is the Optimal Approach?" Frontiers in Oncology, vol. 16, 2026, p. 1775350, https://doi.org/10.3389/fonc.2026.1775350.